GLABF
Gemina Laboratories Ltd.
Price Chart
Latest Quote
$0.05
+0.00 (+0.00%)
Current Price
| Previous Close | $0.05 |
| Open | $0.06 |
| Day High | $0.06 |
| Day Low | $0.04 |
| Volume | 244,000 |
Stock Information
Note: Financial values converted from CAD to USD
| Shares Outstanding | 76.57M |
| Total Debt | $169K |
| Cash Equivalents | $-431 |
| Revenue | $8K |
| Net Income | $-2.06M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $3.83M |
| EPS (TTM) | $-0.03 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.07M |
| Sales | $8K |
| Income | $-2.06M |
| Book/sh | $-0.05 |
| Cash/sh | $-0.00 |
Financial Ratios
| Quick Ratio | 0.00 |
| Current Ratio | 0.01 |
Returns & Margins
| ROA | -134.42% |
| Gross Margin | 100.00% |
| Operating Margin | -26104.50% |
Ownership
| Insider Ownership | 44.72% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 351.95 |
| P/B | -1.06 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.05 |
| SMA50 | $0.05 |
| SMA200 | $0.13 |
| RSI | nan |
| ATR | 0.0014 |
| Shares Float | 43.67M |
| Volatility | -0.07 |
| Rel Volume | 20.00 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | +0.00% |
| 6 Months | -44.44% |
| YTD | +0.00% |
| Year | -91.83% |
| 3 Years | -90.74% |
| 10 Years | -88.10% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $0.05 | 244,000 |
| 2026-06-22 | $0.05 | 0 |
| 2026-06-18 | $0.05 | 0 |
| 2026-06-17 | $0.05 | 0 |
| 2026-06-16 | $0.05 | 0 |
| 2026-06-15 | $0.05 | 0 |
| 2026-06-12 | $0.05 | 0 |
| 2026-06-11 | $0.05 | 0 |
| 2026-06-10 | $0.05 | 0 |
| 2026-06-09 | $0.05 | 0 |
| 2026-06-08 | $0.05 | 0 |
| 2026-06-05 | $0.05 | 0 |
| 2026-06-04 | $0.05 | 0 |
| 2026-06-03 | $0.05 | 0 |
| 2026-06-02 | $0.05 | 0 |
| 2026-06-01 | $0.05 | 0 |
| 2026-05-29 | $0.05 | 0 |
| 2026-05-28 | $0.05 | 0 |
| 2026-05-27 | $0.05 | 0 |
| 2026-05-26 | $0.05 | 0 |
About Gemina Laboratories Ltd.
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada.
đ° Latest News
No news articles available at the moment. Check back later for updates on GLABF.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $164,073 | $19,261 | - | $539 |
| Total Expenses | $3,911,951 | $5,197,528 | $5,980,126 | $4,734,374 |
| Other Income Expense | $2,366 | - | - | - |
| Net Non Operating Interest Income Expense | $-164,073 | $-19,261 | $1,099 | $-539 |
| Interest Expense Non Operating | $164,073 | $19,261 | - | $539 |
| Operating Expense | $3,911,951 | $5,197,528 | $5,980,126 | $4,734,374 |
| General And Administrative Expense | $2,635,864 | $2,605,340 | $1,798,966 | $1,986,113 |
| Rent Expense Supplemental | - | - | - | $0 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-4,073,658 | $-5,216,789 | $-5,979,027 | $-4,734,913 |
| Net Interest Income | $-164,073 | $-19,261 | $1,099 | $-539 |
| Normalized Income | $-4,076,024 | $-5,216,789 | $-5,979,027 | $-4,734,913 |
| Net Income From Continuing And Discontinued Operation | $-4,073,658 | $-5,216,789 | $-5,979,027 | $-4,734,913 |
| Total Operating Income As Reported | $-3,911,951 | $-5,197,528 | - | - |
| Net Income Common Stockholders | $-4,073,658 | $-5,216,789 | $-5,979,027 | $-4,734,913 |
| Net Income | $-4,073,658 | $-5,216,789 | $-5,979,027 | $-4,734,913 |
| Net Income Including Noncontrolling Interests | $-4,073,658 | $-5,216,789 | $-5,979,027 | $-4,734,913 |
| Net Income Continuous Operations | $-4,073,658 | $-5,216,789 | $-5,979,027 | $-4,734,913 |
| Pretax Income | $-4,073,658 | $-5,216,789 | $-5,979,027 | $-4,734,913 |
| Special Income Charges | $2,366 | $0 | - | - |
| Operating Income | $-3,911,951 | $-5,197,528 | $-5,980,126 | $-4,734,374 |
| Interest Income | - | $0 | $1,099 | - |
| Interest Income Non Operating | - | $0 | $1,099 | - |
| Depreciation Amortization Depletion Income Statement | - | $0 | $31,453 | $43,028 |
| Depreciation And Amortization In Income Statement | - | $0 | $31,453 | $43,028 |
| Depreciation Income Statement | - | $0 | $31,453 | $43,028 |
| Per Share | ||||
| Diluted EPS | $-0.06 | $-0.07 | $-0.10 | $-0.10 |
| Basic EPS | $-0.06 | $-0.07 | $-0.10 | $-0.10 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-3,798,712 | $-5,104,160 | $-5,929,844 | $-4,690,540 |
| Total Unusual Items | $2,366 | $0 | - | - |
| Total Unusual Items Excluding Goodwill | $2,366 | $0 | - | - |
| Reconciled Depreciation | $113,239 | $93,368 | $50,282 | $43,834 |
| EBITDA (Bullshit earnings) | $-3,796,346 | $-5,104,160 | $-5,929,844 | $-4,690,540 |
| EBIT | $-3,909,585 | $-5,197,528 | $-5,980,126 | $-4,734,374 |
| Diluted Average Shares | $74,060,030 | $72,453,309 | $60,190,253 | $47,658,574 |
| Basic Average Shares | $74,060,030 | $72,453,309 | $60,190,253 | $47,658,574 |
| Diluted NI Availto Com Stockholders | $-4,073,658 | $-5,216,789 | $-5,979,027 | $-4,734,913 |
| Gain On Sale Of Ppe | $-20,467 | $0 | - | - |
| Other Special Charges | $-22,833 | - | - | - |
| Research And Development | $1,276,087 | $2,592,188 | $4,149,707 | $2,705,233 |
| Selling General And Administration | $2,635,864 | $2,605,340 | $1,798,966 | $1,986,113 |
| Other Gand A | $1,173,788 | $1,591,595 | $1,257,892 | $1,553,238 |
| Insurance And Claims | $0 | $19,175 | $46,717 | $0 |
| Salaries And Wages | $1,462,076 | $994,570 | $494,357 | $432,875 |
| Rent And Landing Fees | - | - | - | $0 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-4,435,079 | $-1,585,194 | $-71,811 | $944,225 |
| Total Assets | $1,438,229 | $1,456,288 | $1,874,984 | $1,420,142 |
| Total Non Current Assets | $1,331,739 | $1,363,621 | $1,312,123 | $40,831 |
| Non Current Prepaid Assets | $22,487 | $0 | - | $0 |
| Investmentin Financial Assets | $994,423 | $994,423 | $994,423 | $0 |
| Current Assets | $106,490 | $92,667 | $562,861 | $1,379,311 |
| Prepaid Assets | $71,079 | $53,187 | $94,051 | $34,885 |
| Receivables | $34,708 | $38,490 | $385,715 | $188,038 |
| Other Receivables | $23,932 | $6,812 | $6,747 | $21,665 |
| Taxes Receivable | $10,653 | $17,100 | $364,621 | $143,102 |
| Cash Cash Equivalents And Short Term Investments | $703 | $990 | $83,095 | $1,156,388 |
| Cash And Cash Equivalents | $703 | $990 | $83,095 | $1,156,388 |
| Cash Financial | $703 | $990 | $83,095 | $1,156,388 |
| Restricted Cash | - | - | - | $0 |
| Debt | ||||
| Net Debt | $998,205 | $199,010 | - | - |
| Total Debt | $1,273,697 | $485,326 | $240,842 | $46,078 |
| Long Term Debt And Capital Lease Obligation | $175,210 | $205,982 | $198,322 | $5,427 |
| Current Debt And Capital Lease Obligation | $1,098,487 | $279,344 | $42,520 | $40,651 |
| Current Debt | $998,908 | $200,000 | - | - |
| Other Current Borrowings | $998,908 | $200,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $5,873,308 | $3,041,482 | $1,946,795 | $475,917 |
| Total Non Current Liabilities Net Minority Interest | $175,210 | $205,982 | $198,322 | $5,427 |
| Current Liabilities | $5,698,098 | $2,835,500 | $1,748,473 | $470,490 |
| Payables And Accrued Expenses | $4,599,611 | $2,556,156 | $1,705,953 | $429,839 |
| Payables | $4,503,544 | $2,406,054 | $1,158,300 | $386,839 |
| Accounts Payable | $2,856,172 | $1,666,561 | $929,031 | $325,946 |
| Equity | ||||
| Common Stock Equity | $-4,435,079 | $-1,585,194 | $-71,811 | $944,225 |
| Total Equity Gross Minority Interest | $-4,435,079 | $-1,585,194 | $-71,811 | $944,225 |
| Stockholders Equity | $-4,435,079 | $-1,585,194 | $-71,811 | $944,225 |
| Gains Losses Not Affecting Retained Earnings | $4,417,912 | $3,893,916 | $3,328,904 | $891,114 |
| Retained Earnings | $-20,838,540 | $-16,764,882 | $-11,548,093 | $-5,569,066 |
| Other Equity Interest | - | $45,000 | - | - |
| Other | ||||
| Ordinary Shares Number | $74,971,037 | $73,325,878 | $65,852,884 | $55,602,992 |
| Share Issued | $74,971,037 | $73,325,878 | $65,852,884 | $55,602,992 |
| Tangible Book Value | $-4,435,079 | $-1,585,194 | $-71,811 | $944,225 |
| Invested Capital | $-3,436,171 | $-1,385,194 | $-71,811 | $944,225 |
| Working Capital | $-5,591,608 | $-2,742,833 | $-1,185,612 | $908,821 |
| Capital Lease Obligations | $274,789 | $285,326 | $240,842 | $46,078 |
| Total Capitalization | $-4,435,079 | $-1,585,194 | $-71,811 | $944,225 |
| Capital Stock | $11,985,549 | $11,240,772 | $8,147,378 | $5,622,177 |
| Common Stock | $11,985,549 | $11,240,772 | $8,147,378 | $5,622,177 |
| Long Term Capital Lease Obligation | $175,210 | $205,982 | $198,322 | $5,427 |
| Current Capital Lease Obligation | $99,579 | $79,344 | $42,520 | $40,651 |
| Current Accrued Expenses | $96,067 | $150,102 | $547,653 | $43,000 |
| Dueto Related Parties Current | $1,647,372 | $739,493 | $229,269 | $60,893 |
| Investments And Advances | $994,423 | $994,423 | $994,423 | $0 |
| Available For Sale Securities | $994,423 | $994,423 | $994,423 | - |
| Net PPE | $314,829 | $369,198 | $317,700 | $40,831 |
| Accumulated Depreciation | $-30,155 | $-31,475 | $-9,676 | $-14,013 |
| Gross PPE | $344,984 | $400,673 | $327,376 | $54,844 |
| Leases | $0 | $48,852 | $32,970 | $19,250 |
| Other Properties | $331,821 | $338,658 | $281,243 | $8,865 |
| Machinery Furniture Equipment | $13,163 | $13,163 | $13,163 | $9,803 |
| Properties | $0 | $0 | $0 | $0 |
| Duefrom Related Parties Current | $123 | $14,578 | $14,347 | $23,271 |
| Buildings And Improvements | - | $0 | $0 | $16,926 |
| Other Investments | - | - | - | $0 |
| Other Short Term Investments | - | - | - | $10,159 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-1,300,975 | $-3,285,034 | $-4,589,196 | $-3,881,523 |
| Operating Activities | ||||
| Operating Cash Flow | $-1,300,975 | $-3,243,680 | $-4,509,583 | $-3,871,720 |
| Cash Flow From Continuing Operating Activities | $-1,300,975 | $-3,243,680 | $-4,509,583 | $-3,871,720 |
| Operating Gains Losses | $20,467 | - | - | - |
| Investing Activities | ||||
| Investing Cash Flow | $18,418 | $-41,354 | $-505,069 | $8,197 |
| Cash Flow From Continuing Investing Activities | $18,418 | $-41,354 | $-505,069 | $8,197 |
| Capital Expenditure | - | $-41,354 | $-79,613 | $-9,803 |
| Net Other Investing Changes | - | - | $3,750 | $18,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $2,604,746 | $4,297,761 | $2,417,435 |
| Financing Cash Flow | $1,282,270 | $3,202,929 | $3,941,359 | $4,137,963 |
| Cash Flow From Continuing Financing Activities | $1,282,270 | $3,202,929 | $3,941,359 | $4,137,963 |
| Net Other Financing Charges | $-27,159 | $-111,352 | $-592,939 | $1,588,252 |
| Net Common Stock Issuance | $0 | $2,604,746 | $4,297,761 | $2,417,435 |
| Common Stock Issuance | $0 | $2,604,746 | $4,297,761 | $2,417,435 |
| Other | ||||
| Repayment Of Debt | $-117,348 | $-90,465 | $-63,463 | $-67,724 |
| Issuance Of Debt | $910,000 | $200,000 | - | - |
| End Cash Position | $703 | $990 | $83,095 | $1,156,388 |
| Beginning Cash Position | $990 | $83,095 | $1,156,388 | $881,948 |
| Changes In Cash | $-287 | $-82,105 | $-1,073,293 | $274,440 |
| Proceeds From Stock Option Exercised | $516,777 | $600,000 | $300,000 | $200,000 |
| Net Issuance Payments Of Debt | $792,652 | $109,535 | $-63,463 | $-67,724 |
| Net Short Term Debt Issuance | $0 | $200,000 | $0 | - |
| Short Term Debt Issuance | $0 | $200,000 | - | - |
| Net Long Term Debt Issuance | $792,652 | $-90,465 | $-63,463 | $-67,724 |
| Long Term Debt Payments | $-117,348 | $-90,465 | $-63,463 | $-67,724 |
| Long Term Debt Issuance | $910,000 | $0 | - | - |
| Net PPE Purchase And Sale | $18,418 | $-41,354 | $-79,613 | $-9,803 |
| Sale Of PPE | $18,418 | $0 | - | - |
| Purchase Of PPE | $0 | $-41,354 | $-79,613 | $-9,803 |
| Change In Working Capital | $1,996,475 | $1,264,031 | $1,015,862 | $112,925 |
| Change In Payables And Accrued Expense | $2,033,072 | $850,203 | $1,276,114 | $308,361 |
| Change In Prepaid Assets | $-40,379 | $66,603 | $-59,166 | $-21,494 |
| Change In Receivables | $3,782 | $347,225 | $-201,086 | $-173,942 |
| Other Non Cash Items | $123,506 | $50,698 | $10,348 | $4,105 |
| Stock Based Compensation | $518,996 | $565,012 | $392,952 | $702,329 |
| Depreciation Amortization Depletion | $113,239 | $93,368 | $50,282 | $43,834 |
| Depreciation And Amortization | $113,239 | $93,368 | $50,282 | $43,834 |
| Depreciation | $113,239 | $93,368 | $50,282 | $43,834 |
| Net Income From Continuing Operations | $-4,073,658 | $-5,216,789 | $-5,979,027 | $-4,734,913 |
| Net Investment Purchase And Sale | - | $0 | $-429,206 | - |
| Purchase Of Investment | - | $0 | $-429,206 | - |
| Net Business Purchase And Sale | - | - | - | $0 |
| Purchase Of Business | - | - | - | $0 |
Fetched: 2026-02-02